U.S., April 21 -- ClinicalTrials.gov registry received information related to the study (NCT07538206) titled 'Vebectotamab Vedotin Combined With Pucotelimab in the Treatment of Locally Advanced Laryngeal Carcinoma' on April 07.
Brief Summary: This is a prospective, single-arm, Phase II clinical trial designed to evaluate the efficacy and safety of vibecotamab combined with putelimab in the treatment of locally advanced laryngeal carcinoma.
Study Start Date: April 23
Study Type: INTERVENTIONAL
Condition:
Head & Neck Cancer
Intervention:
DRUG: Vibecotamab Injection
Treatment of locally advanced laryngeal carcinoma with vibecotamab plus putelimab
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Tang-Du Hospital
Published by HT Digita...